Skip to main content

NanoCell Therapeutics, Inc.

NanoCell Therapeutics, Inc.

Non-viral DNA-based in vivo gene therapy platform, transforming adoptive cell therapy into in vivo gene therapy. We primarily develop in vivo CAR-TCR therapies, using proprietary cell-directed lipid nanoparticles for delivery of stably integrating DNA, to provide durable efficacy.

Address

Wayne
PA
United States
Visit website

Contact Exhibitor


Loading
View all Exhibitors
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors